| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Tiphaine Christiane Martin
|
|||||||
| GSE197235 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [ChIP-seq]
|
8 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198432 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas.
|
300 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198425 |
Next Generation Sequencing of Primary Melanocytes, Epgn1, and Epgn3 Melanoma Cell lines [RNA-seq]
|
24 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198429 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [Nanostring_sample1]
|
35 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198430 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [nanotstring_sample2]
|
124 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198431 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [Nanostring_sample3]
|
82 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198426 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [SKMel147]
|
6 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE198427 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [YUCHIME]
|
6 | Tiphaine Christiane Martin | May 08, 2024 | ||||
| GSE229576 |
Effect of vehicle or drug treatment on gene expression in p53-null and p53Y220C stable cell lines
|
16 | Tiphaine Christiane Martin | Sep 11, 2024 | ||||
| GSE277017 |
Effect of vehicle or drug treatment on gene expression in BxPC3 cell line
|
9 | Tiphaine Christiane Martin | Sep 26, 2024 | ||||
| GSE161180 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas
|
46 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE186382 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [single cell CD45+ YUMM 2.1]
|
4 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE218359 |
CD34+ HSPC CITE-seq for day 0 and Day 1 and Day 4 under VPA
|
10 | Tiphaine Christiane Martin | Apr 11, 2023 | ||||
| GSE148379 |
Cooperation between distinct cancer drivers dictates inter-tumor heterogeneity in hepatocellular carcinoma
|
60 | Tiphaine Christiane Martin | Dec 16, 2020 | ||||
| GSE155180 |
Mitochondrial activity linked to CD34+CD90+EPCR+ phenotype determines the functional fitness of ex vivo expanded HSCs
|
6 | Tiphaine Christiane Martin | Nov 20, 2020 | ||||
| GSE155386 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [I]
|
12 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE161177 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [YUMMER1.7]
|
9 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE161178 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [YUMM 2.1]
|
9 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE155394 |
Combined blockade of B7-H3 and CD47 immune checkpoints is a new therapeutic strategy for β-catenin driven melanomas [transfection]
|
12 | Tiphaine Christiane Martin | Oct 30, 2023 | ||||
| GSE198428 |
An epigenetic gene signature underlies phenotype switching in early stage melanomas [RPPA]
|
15 | Tiphaine Christiane Martin | May 08, 2024 |
